Providence Autologous Stem Cell Transplant Program offers treatment for a broad range of diseases, including non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma, acute leukemia and testicular cancer.

Our program is accredited by the Foundation for the Accreditation of Cellular Therapy. FACT accreditation allows us to perform transplant protocols through the Bone Marrow Transplant Clinical Trials Network and Southwest Oncology Group, one of the largest oncology research cooperative groups in the United States.

We offer access to clinical trials and provide personal service to cancer patients in the state-of-the-art Providence Cancer Center on the campus of Providence Portland Medical Center.